Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
- Andrew D. Santeusanio and
- Monica M. Bowen
In Table 2 on p. 263 of this article, the authors inadvertently included positive instead of negative percentage changes in A1C for 1-year outcomes. The corrected table is shown below. The online version of this article was updated on 14 September 2018 to reflect this change.
View this table:
TABLE 2.
Addition of Noninsulin Agent Versus Prandial Insulin
- © 2018 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
In this Issue
November 2018, 31(4)
Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
